ArticleCancer gene therapy2024

An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously.

Qingming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.